RxDoctor Payments Data

Susan Mitchell

Nurse Practitioner · Tulsa, OKNPI 1013452499

Payments from drug & device makers

$2,848in general payments, 2019–2025

Across 121 payments — averaging $23.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$410
  • AbbVie$262
  • Boston Scientific$258
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$207
  • Nevro Corp.$207
  • Averitas Pharma Inc.$183
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$2,848100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,848 in reported general payments places this provider in the 85th percentile of 824 nurse practitioner providers in Oklahoma.

See all nurse practitioner providers in Oklahoma

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl19$16,230
Lidocaine15$1,663
Gabapentin129$1,652
Tizanidine Hcl95$1,020
Methocarbamol52$815
Baclofen56$619
Pregabalin22$429
Duloxetine Hcl35$339
Cyclobenzaprine Hcl42$208
Meloxicam21$32

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$410$16,23019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 824 nurse practitioner providers in Oklahoma.

Other nurse practitioner in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →